Median progression-free survival was 17.7 months with TACE-ablation versus 7.3 months with TACE alone.
Will Morton is a journalist at AuntMinnie.com. With a strong foundation in medicine and healthcare, he covers topics such as digital x-ray, molecular imaging, and various medical specialties, including oncology and public health. Will's work has also been featured in NewsBreak, Cook Medical Australia, LabPulse, and DrBicuspid.












